Home
Company
COMPANY
关于
Company
Company
Culture
Honor
Product
PRODUCT
产品
Product
Telmisartan intermediates
Vildagliptin intermediates
Etoricoxib intermediate
Gliquidone and intermediates
Rilpivirine intermediate
Apixaban intermediates
Pazopanib intermediate
Ceritinib intermediate
Other products
News
news
新闻
News
Company news
Industry news
Announcement
Quality&EHS
Quality
质量
Quality &EHS
Quality system
Environmental protection
Production safety
Recruitment
JOB
招聘
Recruitment
Join us
Job list
Online delivery
Contact us
139-6116-5336
(Mr. Min)
180-1221-6066
( Mr.Wang)
Chinese
Industry news
首页
>
News
>
Industry news
Company news
Industry news
Announcement
EN
/
CN
Home
Company
Company
Culture
Honor
Product
Telmisartan intermediates
Vildagliptin intermediates
Etoricoxib intermediate
Gliquidone and intermediates
Rilpivirine intermediate
Apixaban intermediates
Pazopanib intermediate
Ceritinib intermediate
Other products
News
Company news
Industry news
Announcement
Quality &EHS
Quality system
Environmental protection
Production safety
Recruitment
Join us
Job list
Online delivery
Contact us
Industry news
The theme "Action Plan for Improving Drug Standards" seminar was held to lead the improvement of drug quality and safety
2024-01-20
More
Industry news
The 35th pharmaceutical economic information Conference was held in Guangzhou International Biological Island
2024-01-17
More
Industry news
By the end of 2024 at the earliest [With biomedical industry investment and financing]
2024-01-17
More
Industry news
Over $17 billion! 2024 medical BD deal can not look back
2024-01-17
More
139-6116-5336